Omnicell (OMCL) Tops Q2 EPS by 29c; Sees FY Bookings as Low End of Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Omnicell Announces Second Quarter 2023 Results
August 1, 2023 4:01 PM EDTTotal GAAP revenues of $299 million
GAAP net income per diluted share of $0.08
Non-GAAP net income per diluted share of $0.57
FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL) (Omnicell, we, our, us, management, or the Company), a leader in transforming the pharmacy care delivery model, today announced results for its second quarter ended June 30, 2023.
Our second quarter results reflect sequential revenue and profit growth, as we exceeded our previously disclosed guidance ranges for total product and service revenues, non-GAAP EBITDA, and non-GAAP earnings per share, said... More
